ATE293970T1 - Lipasehemmer enthaltende pharmazeutische zusammensetzungen - Google Patents

Lipasehemmer enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE293970T1
ATE293970T1 AT99940127T AT99940127T ATE293970T1 AT E293970 T1 ATE293970 T1 AT E293970T1 AT 99940127 T AT99940127 T AT 99940127T AT 99940127 T AT99940127 T AT 99940127T AT E293970 T1 ATE293970 T1 AT E293970T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
lipase inhibitors
containing lipase
inhibitors
Prior art date
Application number
AT99940127T
Other languages
English (en)
Inventor
Manuela Hug
Hans-Peter Maerki
Marcel Meier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE293970T1 publication Critical patent/ATE293970T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • General Preparation And Processing Of Foods (AREA)
AT99940127T 1998-08-14 1999-08-02 Lipasehemmer enthaltende pharmazeutische zusammensetzungen ATE293970T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115311 1998-08-14
EP99109516 1999-05-12
PCT/EP1999/005607 WO2000009122A1 (en) 1998-08-14 1999-08-02 Pharmaceutical compositions containing lipase inhibitors

Publications (1)

Publication Number Publication Date
ATE293970T1 true ATE293970T1 (de) 2005-05-15

Family

ID=26149537

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99940127T ATE293970T1 (de) 1998-08-14 1999-08-02 Lipasehemmer enthaltende pharmazeutische zusammensetzungen

Country Status (19)

Country Link
US (1) US6358522B1 (de)
EP (1) EP1105122B1 (de)
JP (1) JP3774118B2 (de)
KR (1) KR20010079635A (de)
CN (1) CN1170534C (de)
AR (1) AR035001A1 (de)
AT (1) ATE293970T1 (de)
AU (1) AU761351B2 (de)
BR (1) BR9912980B1 (de)
CA (1) CA2340056C (de)
CO (1) CO5130009A1 (de)
DE (1) DE69924999T2 (de)
DK (1) DK1105122T3 (de)
ES (1) ES2242413T3 (de)
MA (1) MA26671A1 (de)
PE (1) PE20000953A1 (de)
PT (1) PT1105122E (de)
TR (1) TR200100471T2 (de)
WO (1) WO2000009122A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299868B1 (en) 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6264937B1 (en) * 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US7048917B1 (en) 1998-01-09 2006-05-23 Genzyme Corporation Fat-binding polymers
EP1112063A4 (de) 1998-09-08 2009-05-13 Smithkline Beecham Corp Tabletten auf der grundlage eines lpstatinderivates und löslicher fasern
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
EP1132389A1 (de) 2000-03-06 2001-09-12 Vernalis Research Limited Neue Azaindolyl-Derivate für die Behandlung von Fettleibigheit
AU2001281846B2 (en) * 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
CN100423715C (zh) * 2000-07-28 2008-10-08 霍夫曼-拉罗奇有限公司 新型药物组合物
BR0112800A (pt) 2000-07-28 2003-07-01 Hoffmann La Roche Utilização de um inibidor de lìpases e de um sequestrante de ácido de bìlis farmaceuticamente aceitáveis e processo para a prevenção e tratamento de enfermidades associadas com altos nìveis de colesterol de plasma
CA2417607C (en) 2000-08-09 2008-01-29 Christine Feinle Lipase inhibitors for the treatment of dyspepsia
JP4047723B2 (ja) 2000-10-16 2008-02-13 エフ．ホフマン−ラ ロシュ アーゲー インドリン誘導体、および５−ｈｔ２受容体リガンドとしてのその使用
GB0030710D0 (en) 2000-12-15 2001-01-31 Hoffmann La Roche Piperazine derivatives
EP1347979B1 (de) 2000-12-27 2007-08-08 F. Hoffmann-La Roche Ag Indolderivate und deren verwendung als 5-ht2b- und 5-ht2c-rezeptorliganden
GB0106177D0 (en) 2001-03-13 2001-05-02 Hoffmann La Roche Piperazine derivatives
KR100621287B1 (ko) 2001-05-21 2006-09-13 에프. 호프만-라 로슈 아게 신경 펩타이드 ｙ 수용체에 대한 리간드로서의 퀴놀린유도체
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US7049345B2 (en) * 2001-06-29 2006-05-23 Genzyme Corporation Fat-binding polymers
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6787558B2 (en) 2001-09-28 2004-09-07 Hoffmann-La Roche Inc. Quinoline derivatives
GB0202015D0 (en) 2002-01-29 2002-03-13 Hoffmann La Roche Piperazine Derivatives
JP4216196B2 (ja) 2002-02-04 2009-01-28 エフ．ホフマン−ラ ロシュ アーゲー Ｎｐｙアンタゴニストとしてのキノリン誘導体
RU2004129285A (ru) 2002-02-28 2005-10-27 Ф.Хоффманн-Ля Рош Аг (Ch) Производные тиазола в качестве антагонистов рецептора npy
EP1501498B1 (de) * 2002-04-26 2009-12-30 F. Hoffmann-La Roche Ag Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
EP1560816A1 (de) 2002-07-05 2005-08-10 F. Hoffmann-La Roche Ag Chinazoline derivate
AU2003253364B2 (en) 2002-08-07 2007-06-07 F. Hoffmann-La Roche Ag Thiazole derivatives
NZ537979A (en) 2002-09-12 2007-08-31 Hoffmann La Roche N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
MXPA05005445A (es) 2002-11-25 2005-08-26 Hoffmann La Roche Derivados de indolilo.
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
GB0314967D0 (en) 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
CA2533464A1 (en) 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag Thiazole derivatives as npy antagonists
RU2006107444A (ru) 2003-08-12 2007-09-20 Ф.Хоффманн-Ля Рош Аг (Ch) 2-амино-5-бензоилтиазолы в качестве антагонистов npy
AU2006243243B2 (en) 2005-05-03 2009-05-14 F. Hoffmann-La Roche Ag Tetracyclic azapyrazinoindolines as 5-HT2 ligands
WO2006132440A1 (ja) 2005-06-09 2006-12-14 Takeda Pharmaceutical Company Limited 固形製剤
EP1945635B1 (de) 2005-08-18 2009-05-06 F.Hoffmann-La Roche Ag Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
WO2007062999A2 (en) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 1,5-substituted indol-2-yl amide derivatives
WO2007063000A1 (en) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 5-substituted indole-2-carboxamide derivatives
EP1968967B1 (de) 2005-11-30 2011-04-27 F. Hoffmann-La Roche AG 1,1-dioxo-thiomorpholinyl-indolyl-methanon-derivate zur verwendung als h3-modulatoren
WO2007065820A1 (en) 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Tricyclic amide derivatives useful for treating obesity
WO2007068620A1 (en) 2005-12-15 2007-06-21 F. Hoffmann-La Roche Ag Pyrrolo[2,3-c]pyridine derivatives
JP2009519293A (ja) 2005-12-16 2009-05-14 エフ．ホフマン−ラ ロシュ アーゲー Ｈ３レセプター調節剤としてのピロロ［２，３−ｂ］ピリジン誘導体
US7432255B2 (en) 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
US7902184B2 (en) 2006-05-30 2011-03-08 Hoffmann-La Roche Inc. Piperazinyl pyrimidine derivatives
US7514433B2 (en) 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
US20080146559A1 (en) 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
CA2686257C (en) * 2007-05-16 2013-07-02 Buckman Laboratories International, Inc. Methods to control organic contaminants in fibers
EP2183237A1 (de) 2007-07-25 2010-05-12 F. Hoffmann-Roche AG Benzofuran- und benzo[b]thiophen-2-carbonsäureamidderivate und deren verwendung als modulatoren des histamin-3-rezeptors
WO2009044380A2 (en) 2007-10-05 2009-04-09 Ranbaxy Laboratories Limited Formulations containing orlistat particles having controlled particle size
MX2010004072A (es) * 2007-10-15 2010-09-14 Inventis Dds Pvt Ltd Composicion farmaceutica de orlistat.
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
WO2010042499A1 (en) 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
GB201122213D0 (en) * 2011-12-23 2012-02-01 Norgine Bv Compositions
CN104546768B (zh) * 2014-12-30 2017-06-16 重庆植恩药业有限公司 含有脂肪酶抑制剂的咀嚼片组合物及其制备方法
CA3025389C (en) * 2016-06-17 2022-11-29 The Procter & Gamble Company Soft chewable composition comprising psyllium
CN112220831A (zh) * 2020-08-07 2021-01-15 天津盛实百草中药科技有限公司 圆苞车前子壳粉在缓解奥利司他副作用中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
US5294451A (en) * 1991-03-29 1994-03-15 Curtice-Burns, Inc. Fat substitute compositions having reduced laxative effects
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JPH09252746A (ja) * 1996-03-22 1997-09-30 Nippon Kankyo Yakuhin Kk 栄養補助食品
JP4202439B2 (ja) * 1996-10-01 2008-12-24 江崎グリコ株式会社 フラボノイド可溶化法、その糖転移法及び高濃度フラボノイド溶液
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions

Also Published As

Publication number Publication date
EP1105122B1 (de) 2005-04-27
AU5418599A (en) 2000-03-06
AR035001A1 (es) 2004-04-14
MA26671A1 (fr) 2004-12-20
BR9912980B1 (pt) 2013-10-22
DE69924999T2 (de) 2006-05-04
JP2002522491A (ja) 2002-07-23
CA2340056A1 (en) 2000-02-24
CA2340056C (en) 2007-01-09
CN1312713A (zh) 2001-09-12
DE69924999D1 (de) 2005-06-02
KR20010079635A (ko) 2001-08-22
AU761351B2 (en) 2003-06-05
BR9912980A (pt) 2001-05-08
ES2242413T3 (es) 2005-11-01
PE20000953A1 (es) 2000-09-26
CO5130009A1 (es) 2002-02-27
JP3774118B2 (ja) 2006-05-10
PT1105122E (pt) 2005-08-31
CN1170534C (zh) 2004-10-13
WO2000009122A1 (en) 2000-02-24
TR200100471T2 (tr) 2001-07-23
DK1105122T3 (da) 2005-08-08
US6358522B1 (en) 2002-03-19
EP1105122A1 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
DK1105122T3 (da) Pharmaceutical compositions containing lipase inhibitors
PT1105123E (pt) Composicoes farmaceuticas contendo inibidores da lipase e quitosano
ID27415A (id) Komposisi farmaseutik
IS5046A (is) Lyfjasamsetningar
DE69940904D1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
PT1066027E (pt) Composicao farmaceutica de topiramato
ID29262A (id) Komposisi farmasi
MA26818A1 (fr) Formulations contenant des inhibiteurs de lipase
DE69900561D1 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
FI973518A0 (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
ID27201A (id) Komposisi farmasi
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
ID30032A (id) Formulasi farmasi
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
DE69830154D1 (de) Pharmazeutische zusammensetzungen
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
EE200000330A (et) Farmatseutilised kompositsioonid
EE200100281A (et) Analgeetiline ravimkoostis
EP1124557A4 (de) Pharmazeutische zusammensetzung
EE200100084A (xx) NOS inhibiitorite uued farmatseutilised kasutusv�imalused
PT1051156E (pt) Composicoes farmaceuticas
NO994436L (no) Farmasöytiske sammensetninger
ZA200100696B (en) Pharmaceutical compositions containing lipase inhibitors
FI981567A0 (fi) Farmaseuttiset koostumukset

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1105122

Country of ref document: EP